Verified Nov 2026
Other
·

San Diego, California
·
Since 2017
Vividion Therapeutics is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $50–100 million, it operates as a wholly owned subsidiary of Bayer AG following acquisition in August 2021. The company develops precision small-molecule therapeutics targeting cancers and immune disorders using its proprietary chemoproteomic platform to identify previously inaccessible protein binding sites.
Vividion Therapeutics, Inc. at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
2017
Headquarters
San Diego, California
Industries
Automotive
Electric Vehicles
Medical
Overview
Vividion Therapeutics is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $50–100 million, it operates as a wholly owned subsidiary of Bayer AG following acquisition in August 2021. The company develops precision small-molecule therapeutics targeting cancers and immune disorders using its proprietary chemoproteomic platform to identify previously inaccessible protein binding sites.
At a glance
Attribute | Detail |
|---|---|
Founded | 2017 |
Headquarters | San Diego, California |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
What Vividion Therapeutics, Inc. makes
The company operates a drug discovery platform integrating chemoproteomics, synthetic chemistry, and proteome-wide target discovery to create first-in-class therapeutics aimed at undruggable proteins in oncology and immunology.
Latest developments
2026-10-15 — Vividion Therapeutics Expands Clinical Development of WRN Inhibitor VVD-214 with Phase 2 Combination Study in First-Line Patients with Advanced Colorectal Cancer — Vividion Therapeutics (vividion.com)
2026-09-29 — Vividion Announces Publication of Clinical Data for VVD-214 in Nature Medicine, Highlighting Potential in Colorectal Cancer — Vividion Therapeutics (vividion.com)
2026-06-23 — Vividion Therapeutics Doses First Patient in Phase Ib Combination Study of WRN Inhibitor VVD-214 in Patients with Advanced Colorectal Cancer — Vividion Therapeutics (vividion.com)
2025-12-22 — Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology — Vividion Therapeutics (vividion.com)
2025-11-12 — Bayer bails on Vividion tumor drug in early-stage clear-out (fiercebiotech.com)
2025-08-13 — Vividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer — Vividion Therapeutics (vividion.com)
Facilities
Vividion Therapeutics, Inc. is headquartered in San Diego, California. Public sources also reference these locations:
San Diego, California — vividion.com
Company details
Vividion is a subsidiary of Bayer AG and maintains a diverse pipeline of candidates focused on precision therapeutics that minimize off-target effects in oncology and autoimmune disease. Vividion Therapeutics, Inc. was founded in 2017, has an estimated 200-500 employees, and is headquartered in San Diego, California.
Frequently asked questions
What does Vividion Therapeutics, Inc. do?
Vividion Therapeutics is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in San Diego, California. With 200–500 employees and estimated revenue of $50–100 million, it operates as a wholly owned subsidiary of Bayer AG following acquisition in August 2021. The company develops precision small-molecule therapeutics targeting cancers and immune disorders using its proprietary chemoproteomic platform to identify previously inaccessible protein binding sites.
Where is Vividion Therapeutics, Inc. headquartered?
Vividion Therapeutics, Inc. is headquartered in San Diego, California (5820 Nancy Ridge Drive, San Diego, California, 92121).
When was Vividion Therapeutics, Inc. founded?
Vividion Therapeutics, Inc. was founded in 2017.
How big is Vividion Therapeutics, Inc.?
Vividion Therapeutics, Inc. has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
